BriefTea
Every story in sixty words
Get the free app no ads · no paywallExplained in plain English
In the UK, the National Institute for Health and Care Excellence (NICE) assesses new drugs like GLP-1s to decide if they offer good value for money for the NHS. They weigh up the drug's benefits against its cost, and if approved, the NHS negotiates the final price with the pharmaceutical company. This process aims to ensure effective treatments are available while managing public spending.
Stories that explain this
Western Isles patients get GLP-1 jabs at almost triple other Scottish rateQuestions this opens up
How does NICE decide value? How do drug companies set prices? Do other countries do this?Related explainers
Who decides local drug availability? How do GLP-1 drugs work? How much do GLP-1 drugs cost? Why do islands skew figures? Who decides drug availability? Who decides global oil prices? How do drug prices work? How does AI develop drugs?The full catalogue
Browse every card filed under D →We would like to count visits and see which links bring readers here. That means storing a random ID in your browser. No cookies, no ads, no profile. How it works.